GPX4 and hepatocellular carcinoma: The Zhang group has demonstrated that activation of the insulin-like growth factor 1 receptor (IGF1R) in HCC cells leads to an increase in GPX4 expression, which is dependent on phosphorylated creatine kinase B (CKB) protein kinase activity.